Fear is a funny thing. In a controlled situation, say a movie theater or roller coaster, it can be exciting. It gets our blood pumping, gets our adrenaline racing. But in the real world, where anything can happen and safety isn’t assured, fears can get out of hand.
The idea of an all-in-one glucose meter that eliminates the need to carry around a bunch of separate D-supplies is so appealing! But in many respects it’s like the mirage of water on the desert horizon that we can never reach.
Follow these 10 tips to “treat yourself” to a healthier, slimmer body.
Thanks to their research which was published in the journal Cell Metabolism, the University of Geneva (UNIGE) scientists identified the underlying mechanisms, proving that life without insulin is possible, and paving the way for new diabetes treatments.
Diabetes pills known as DPP-4 therapies got a mixed safety report on Monday as studies showed they did not raise the risk of heart attacks but might be linked to heart failure, where the heart fails to pump blood adequately.
I’ve just started on the Dexcom G4 continuous glucose monitor myself, and a few weeks in I am absolutely loving the accuracy and sense of security it’s giving me at all hours of the day. It’s already provided early notice of a few low blood sugars, especially during the overnight hours that are the biggest […]
Apps for managing diabetes and calculating the risk of cardiovascular disease are among the top 10 apps doctors recommend to their patients, according to researchers at Medical Economics.
Why do some meters need to be “coded” and others do not? Is there a valid reason that strips come in boxes of 50 and 100?
Can’t sleep? Got the PMS blues? Before you open your medicine cabinet, step into your kitchen.
This has been a VERY busy August in terms of diabetes activity and advocacy, so while it’s always tough to pinpoint just a handful of the great posts around The Blogosphere. We found it particularly challenging this month! But we managed somehow. So here’s our monthly snapshot of posts we found particularly noteworthy
According to the National Diabetes Information Clearinghouse, as many as 70% of people with diabetes eventually develop neuropathy. Pain from this condition is often difficult to treat, but researchers at the University of Virginia have recently made a discovery in mice that may shed light on how to effectively reduce nerve pain.
Eating more whole fruits, particularly blueberries, grapes, and apples, was significantly associated with a lower risk of type 2 diabetes, according to a new study led by Harvard School of Public Health (HSPH) researchers.
Biologists at the University of Fribourg have been looking at a threadworm gene which also occurs in humans. This gene could be central to a genetic system which is responsible for development, reproduction and the ageing process.
Participants were between the ages of 2-19 years and had a history of diabetes ranging from 6 months to 15 ½ years. Both treatment groups started with the same HbA1c levels. During follow-up treatment, those on the insulin pump displayed an improved HbA1c level.
The hemoglobin A1c test is a common blood test used to determine how well patients are managing their diabetes. It is also called the HbA1c, glycohemoglobin, or glycated hemoglobin test. The test is commonly used to screen for type 1 and 2 diabetes.
Eating more whole fruits, particularly blueberries, grapes and apples, is associated with a lower risk of type 2 diabetes, with greater fruit juice consumption having an adverse effect, a paper published today in BMJ suggests.
Nutritionists have rhapsodized about the various benefits of broccoli — the cruciferous vegetable is stuffed with vitamins A, B, K, C, as well as nutrients such as potassium, zinc and fiber — and arthritis sufferers may soon join them.
Children who took the drugs—whose brand names include Risperdal, Seroquel, Abilify and Zyprexa—had a three-fold increased risk of Type 2 diabetes compared to children with the same conditions who took other medications.
he test strips were taken from at least seven different vials of one manufacturing lot. Over at least ten days, the patients tested their blood sugar with the meter and then a second sample was taken for analysis in a lab. It’s quite an interesting read and I have broken it down into accuracy of […]
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network (ITN), are published today in The Lancet Diabetes & Endocrinology.